Business
Channel Therapeutics Corporation (CHRO)’s -4.67% Fall Drives It Into Interest-Losing Territory For Investors
Channel Therapeutics Corporation (AMEX:CHRO) has a beta value of 3.78 and has seen 0.59 million shares traded in the recent trading session. The company, currently
